About BioCircuit
BioCircuit is a company based in Atlanta (United States) founded in 2016.. BioCircuit has raised $13.65 million across 7 funding rounds from investors including NIH, HHS and Masters Capital Management. BioCircuit offers products and services including Nerve Tape. BioCircuit operates in a competitive market with competitors including Avation, Epineuron, Tulavi Nerve Therapeutics, Micro Leads and Renerva, among others.
- Headquarter Atlanta, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biocircuit Technologies
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.65 M (USD)
in 7 rounds
-
Latest Funding Round
$1.89 M (USD), Grant
Sep 22, 2023
-
Investors
NIH
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioCircuit
BioCircuit offers a comprehensive portfolio of products and services, including Nerve Tape. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sutureless tool for faster and stronger nerve repairs in surgeries.
Unlock access to complete
Unlock access to complete
Funding Insights of BioCircuit
BioCircuit has successfully raised a total of $13.65M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $1.89 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $1.9M
-
First Round
First Round
(15 May 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - BioCircuit | Valuation |
investors |
|
| Sep, 2022 | Amount | Series B - BioCircuit | Valuation | Masters Capital Management | |
| May, 2021 | Amount | Grant - BioCircuit | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioCircuit
BioCircuit has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Masters Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed & early stage sector-agnostic venture capital firm funding companies in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioCircuit
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioCircuit
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biocircuit Comparisons
Competitors of BioCircuit
BioCircuit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, Epineuron, Tulavi Nerve Therapeutics, Micro Leads and Renerva, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
|
|
| domain | founded_year | HQ Location |
Medical devices for peripheral nerve injury treatment are provided.
|
|
| domain | founded_year | HQ Location |
Therapeutic devices for neurally mediated diseases are developed.
|
|
| domain | founded_year | HQ Location |
Micro-cuff electrodes and wireless pulse generators for neuromodulation are developed.
|
|
| domain | founded_year | HQ Location |
Implants for peripheral nerve repair are developed for injury treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biocircuit
Frequently Asked Questions about BioCircuit
When was BioCircuit founded?
BioCircuit was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is BioCircuit located?
BioCircuit is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Who is the current CEO of BioCircuit?
Michelle Jarrard is the current CEO of BioCircuit.
Is BioCircuit a funded company?
BioCircuit is a funded company, having raised a total of $13.65M across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.7M, raised on May 15, 2019.
What does BioCircuit do?
BioCircuit was founded in 2016 in Atlanta, United States, within the medical devices sector. Non-invasive electrophysiology devices are produced by the company to assess peripheral nerve activity. A multielectrode array-based technology, supported by proprietary algorithms, is utilized for testing nerve function. Operations focus on advancing diagnostic tools for neurological monitoring, with leadership provided by CEO Michelle Jarrard.
Who are the top competitors of BioCircuit?
BioCircuit's top competitors include Avation, Tulavi Nerve Therapeutics and Epineuron.
What products or services does BioCircuit offer?
BioCircuit offers Nerve Tape.
Who are BioCircuit's investors?
BioCircuit has 5 investors. Key investors include NIH, HHS, Masters Capital Management, GRA Venture Fund, and Alsora Capital.